AZN vs. OPRA
Compare and contrast key facts about AstraZeneca PLC (AZN) and Opera Limited (OPRA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AZN or OPRA.
Correlation
The correlation between AZN and OPRA is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
AZN vs. OPRA - Performance Comparison
Key characteristics
AZN:
-0.48
OPRA:
0.63
AZN:
-0.40
OPRA:
1.28
AZN:
0.95
OPRA:
1.15
AZN:
-0.34
OPRA:
0.54
AZN:
-0.61
OPRA:
2.25
AZN:
15.45%
OPRA:
14.00%
AZN:
22.84%
OPRA:
51.64%
AZN:
-48.94%
OPRA:
-72.85%
AZN:
-22.12%
OPRA:
-33.16%
Fundamentals
AZN:
$223.51B
OPRA:
$1.56B
AZN:
$2.49
OPRA:
$0.93
AZN:
28.95
OPRA:
18.71
AZN:
4.07
OPRA:
3.00
AZN:
5.47
OPRA:
1.68
AZN:
$54.98B
OPRA:
$522.43M
AZN:
$44.75B
OPRA:
$265.69M
AZN:
$17.70B
OPRA:
$110.97M
Returns By Period
In the year-to-date period, AZN achieves a 4.16% return, which is significantly higher than OPRA's -7.51% return.
AZN
4.16%
3.70%
5.49%
-10.79%
7.24%
10.12%
OPRA
-7.51%
23.63%
-3.59%
32.07%
29.83%
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AZN vs. OPRA — Risk-Adjusted Performance Rank
AZN
OPRA
AZN vs. OPRA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for AstraZeneca PLC (AZN) and Opera Limited (OPRA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
AZN vs. OPRA - Dividend Comparison
AZN's dividend yield for the trailing twelve months is around 2.27%, less than OPRA's 4.66% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AZN AstraZeneca PLC | 2.27% | 2.27% | 2.15% | 2.14% | 2.40% | 2.80% | 2.81% | 3.61% | 3.95% | 5.01% | 4.06% | 3.98% |
OPRA Opera Limited | 4.66% | 4.22% | 9.07% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
AZN vs. OPRA - Drawdown Comparison
The maximum AZN drawdown since its inception was -48.94%, smaller than the maximum OPRA drawdown of -72.85%. Use the drawdown chart below to compare losses from any high point for AZN and OPRA. For additional features, visit the drawdowns tool.
Volatility
AZN vs. OPRA - Volatility Comparison
The current volatility for AstraZeneca PLC (AZN) is 8.91%, while Opera Limited (OPRA) has a volatility of 16.47%. This indicates that AZN experiences smaller price fluctuations and is considered to be less risky than OPRA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
AZN vs. OPRA - Financials Comparison
This section allows you to compare key financial metrics between AstraZeneca PLC and Opera Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AZN vs. OPRA - Profitability Comparison
AZN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AstraZeneca PLC reported a gross profit of 11.35B and revenue of 13.59B. Therefore, the gross margin over that period was 83.5%.
OPRA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Opera Limited reported a gross profit of 64.35M and revenue of 143.44M. Therefore, the gross margin over that period was 44.9%.
AZN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AstraZeneca PLC reported an operating income of 3.67B and revenue of 13.59B, resulting in an operating margin of 27.0%.
OPRA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Opera Limited reported an operating income of 21.94M and revenue of 143.44M, resulting in an operating margin of 15.3%.
AZN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AstraZeneca PLC reported a net income of 2.92B and revenue of 13.59B, resulting in a net margin of 21.5%.
OPRA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Opera Limited reported a net income of 18.38M and revenue of 143.44M, resulting in a net margin of 12.8%.